Federal Policy Meets Clinical Innovation: A Conversation With ASTP/ONC is starting in

Medicines In Development: Mental Illness 2012

September 1, 2012
A report has been released by the Pharmaceutical Research and Manufacturers of America listing medications in development to treat mental illnesses. The list provides the status of each medication regarding its approval by the U.S. Food and Drug Administration, the manufacturer, and the targeted condition. There are about 200 medications in the development pipeline, with 52 for depression, 37 for schizophrenia, and 26 for anxiety.
Download the Report
. . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.